Train Babcock Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$609K Buy
11,329
+1,871
+20% +$104K 0.27% 65
2017
Q3
$578K Buy
9,458
+209
+2% +$12.7K 0.32% 48
2017
Q2
$565K Sell
9,249
-2,865
-24% -$174K 0.25% 70
2017
Q1
$734K Sell
12,114
-314
-3% -$19.1K 0.33% 60
2016
Q4
$698K Sell
12,428
-488
-4% -$28.6K 0.29% 70
2016
Q3
$769K Buy
12,916
+231
+2% +$13.5K 0.31% 66
2016
Q2
$697K Hold
12,685
0.28% 71
2016
Q1
$641K Sell
12,685
-63
-0.5% -$3.09K 0.26% 72
2015
Q4
$643K Buy
12,748
+748
+6% +$37.7K 0.25% 77
2015
Q3
$566K Buy
12,000
+4
+0% +$212 0.2% 82
2015
Q2
$651K Hold
11,996
0.21% 83
2015
Q1
$658K Hold
11,996
0.21% 83
2014
Q4
$650K Buy
11,996
+553
+5% +$30.8K 0.21% 82
2014
Q3
$647K Hold
11,443
0.22% 83
2014
Q2
$632K Hold
11,443
0.21% 84
2014
Q1
$620K Hold
11,443
0.2% 84
2013
Q4
$547K Hold
11,443
0.19% 82
2013
Q3
$520K Hold
11,443
0.2% 78
2013
Q2
$507K Buy
+11,443
New +$511K 0.19% 76

Other funds holding MRK

Train Babcock Advisors's MRK Position: Q4 2017 in Review

Train Babcock Advisors increased its Merck (MRK) stake by 20% in Q4 2017, buying an estimated $104K and bringing the position to 11,329 shares worth $609K. The position accounts for 0.27% of the portfolio, ranked #65.

Train Babcock Advisors first reported a position in MRK in Q2 2013 and has held it in 19 quarters since. The position peaked at $769K in Q3 2016. 2,009 funds tracked by Wall St. Rank hold MRK as of Q4 2017.

  • Train Babcock Advisors held 11,329 shares of Merck worth $609K as of Q4 2017.
  • Train Babcock Advisors bought 1,871 Merck shares in Q4 2017, an estimated $104K.
  • Merck made up 0.27% of Train Babcock Advisors's portfolio in Q4 2017, its #65 holding.
  • Train Babcock Advisors first reported a position in Merck in Q2 2013 and has held it in 19 quarters since.
  • Train Babcock Advisors's Merck position peaked at $769K in Q3 2016.
  • 2,009 funds tracked by Wall St. Rank held Merck as of Q4 2017.

Based on Train Babcock Advisors's 13F filing for Q4 2017, filed 10 Jan 2018.